AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32861156 — intervention group
Group type: COMPARATOR
Intervention: Capsular typing by wzi gene sequencing
Number of subjects: 60
Study 32861156 — intervention group
Group type: EXPERIMENTAL
Intervention: MLVA
Number of subjects: 60
Study 32861156 — intervention group
Group type: COMPARATOR
Intervention: wzi gene sequencing
Number of subjects: 60
Study 36307862 — intervention group
Group type: EXPERIMENTAL
Intervention: STARC-SUD (Skills Training in Affect Regulation - a Culture-sensitive approach)
Number of subjects: 286
Study 32803820 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS reminder group
Number of subjects: 2225
Study 32803820 — intervention group
Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 2225
Study 35320892 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 200mg bid + Cediranib 30mg qd (arm 1)
Number of subjects: 70
Study 35320892 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 300mg bid + Durvalumab 1,500mg q4w (arm 2)
Number of subjects: 70
Study 35320892 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab 1,500 mg q4w + Pegylated liposomal doxorubicin (PLD) or Topotecan or Weekly Paclitaxel (arm 3)
Number of subjects: 70
Study 35320892 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab 1,500 mg q4w + Tremelimumab 75mg q4w + PLD or Topotecan or Weekly Paclitaxel (arm 4)
Number of subjects: 70
Study 35320892 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab 1,500 mg q4w + Tremelimumab 300mg [1 dose] + Weekly Paclitaxel [60 mg/m² D1,8,15 q4w for 4 cycles] (arm 5)
Number of subjects: 70
Study 32752077 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 27
Study 32752077 — intervention group
Group type: COMPARATOR
Intervention: NICE diet
Number of subjects: 27
Study 32752077 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 27
Study 35114331 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Oral Hygiene Advice (OHA) with intra-oral camera (IOC) images
Number of subjects: 22
Study 35114331 — intervention group
Group type: COMPARATOR
Intervention: Standard Oral Hygiene Advice (OHA)
Number of subjects: 22
Study 33549723 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ACL reconstruction (ACLR)
Number of subjects: 121
Study 33549723 — intervention group
Group type: COMPARATOR
Intervention: Optional delayed ACLR
Number of subjects: 121
Study 33549723 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ACLR
Number of subjects: 121
Study 33549723 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation alone
Number of subjects: 121
Study 34158427 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 15 mg/kg (Group M)
Number of subjects: 132
Study 34158427 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group N)
Number of subjects: 132
Study 35970278 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of IV tranexamic acid preoperatively
Number of subjects: 100
Study 35970278 — intervention group
Group type: COMPARATOR
Intervention: No tranexamic acid (control group)
Number of subjects: 100
Study 33079265 — intervention group
Group type: EXPERIMENTAL
Intervention: Severely obese adolescents with LVH (n=24, 55.8%)
Number of subjects: 43
Study 33079265 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular mass index
Number of subjects: 43
Study 33079265 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventricular septum thickness (IVST)
Number of subjects: 43
Study 35444271 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive weight-loss intervention (9 contact points in 6 months)
Number of subjects: 140
Study 35444271 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive weight-loss intervention
Number of subjects: 140
Study 35444271 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study 32894873 — intervention group
Group type: EXPERIMENTAL
Intervention: Delegation Agreement (D-A) implementation
Number of subjects: 30
Study 33991337 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of diesel exhaust particles (DEP) at nontoxic concentrations
Number of subjects: 76
Study 33991337 — intervention group
Group type: COMPARATOR
Intervention: Topical application of an antioxidant mixture
Number of subjects: 76
Study 32432487 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (education around infant crying and abusive head trauma)
Number of subjects: 0
Study 32432487 — intervention group
Group type: COMPARATOR
Intervention: Control (non-US-born mothers)
Number of subjects: 0
Study 35054157 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal fat-soluble vitamin formulation containing vitamin K2 (2667 IU vitamin A, 1333 IU beta-carotene, 4000 IU D3, 150 IU E, 2 mg K1, 400 μg K2)
Number of subjects: 100
Study 35054157 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal fat-soluble vitamin formulation containing vitamin K2
Number of subjects: 100
Study 35054157 — intervention group
Group type: COMPARATOR
Intervention: Standard vitamin preparations (2500 IU vitamin A, 1428 IU beta-carotene, 4000 IU D3, 150 IU E, 2.14 mg K1)
Number of subjects: 100
Study 33049119 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized ipratropium bromide (500 µg in 0.9% saline per dose)
Number of subjects: 30
Study 33049119 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nebulized 0.9% saline)
Number of subjects: 30
Study 35064811 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric Nordic Hamstring Exercise (NHE) training
Number of subjects: 23
Study 35064811 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular handball training without NHE)
Number of subjects: 23
Study 33857858 — intervention group
Group type: EXPERIMENTAL
Intervention: Household incentives with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160
Study 33857858 — intervention group
Group type: EXPERIMENTAL
Intervention: Village incentives with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160
Study 33857858 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved sanitation coverage
Number of subjects: 160
Study 33857858 — intervention group
Group type: COMPARATOR
Intervention: No subsidy with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160
Study 33857858 — intervention group
Group type: EXPERIMENTAL
Intervention: Both household and village incentives with Community‐Led Total Sanitation (CLTS)
Number of subjects: 160
Study 33762240 — intervention group
Group type: EXPERIMENTAL
Intervention: EE information plus standard care (INT)
Number of subjects: 105
Study 33762240 — intervention group
Group type: COMPARATOR
Intervention: Standard weight management care (SC)
Number of subjects: 105
Study 33185345 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil spray (50 mg) on an empty stomach
Number of subjects: 50
Study 33185345 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil tablet (50 mg) on an empty stomach
Number of subjects: 50
Study 33185345 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil spray (50 mg) after a meal
Number of subjects: 50
Study 33185345 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil tablet (50 mg) after a meal
Number of subjects: 50
Study 35100025 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-mediated virtual reality gaming + conventional physiotherapy
Number of subjects: 40
Study 35100025 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 40
Study 33420114 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose regimen of hepatitis A vaccine (0, 6 months)
Number of subjects: 116
Study 33420114 — intervention group
Group type: COMPARATOR
Intervention: 3-dose regimen of hepatitis A vaccine (0, 1, 6 months)
Number of subjects: 116
Study 32368869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenabasum (cannabinoid type 2 receptor agonist)
Number of subjects: 0
Study 32368869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34250931 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery-based rehabilitation (MIG)
Number of subjects: 29
Study 34250931 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation (CG)
Number of subjects: 29
Study 34145734 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counselling at four routine visits focusing on dietary fat, fibre, and saccharose intake
Number of subjects: 399
Study 34145734 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 399
Study 33414363 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavior therapy (TF-CBT)
Number of subjects: 36
Study 32967439 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up (nurse or pharmacist)
Number of subjects: 2091
Study 32967439 — intervention group
Group type: COMPARATOR
Intervention: Clinic follow-up (physician)
Number of subjects: 2091
Study 35129519 — intervention group
Group type: EXPERIMENTAL
Intervention: No touch technique
Number of subjects: 853
Study 35129519 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 853
Study 33690245 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated pulsating support system air mattress used for 30 days in the prevention group (n = 22)
Number of subjects: 40
Study 33690245 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated pulsating support system air mattress used for 30 days in the treatment group (n = 18)
Number of subjects: 40
Study 33690245 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort assessment of the mattress by caregivers, family members, and residents
Number of subjects: 40
Study 32969007 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended training (didactic and hands-on)
Number of subjects: 43
Study 32969007 — intervention group
Group type: COMPARATOR
Intervention: Didactic training only
Number of subjects: 43
Study 36173596 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine (1-1.5 mg/day for 3 days, then 0.5 mg/day for 11 days) and Prednisone (60 mg/day for 3 days)
Number of subjects: 54
Study 36173596 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine/Prednisone
Number of subjects: 54
Study 36173596 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (intravenous dexamethasone)
Number of subjects: 54
Study 35361560 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (water-only 24-h fasting twice-per-week for 4 weeks and once-per-week for 22 weeks)
Number of subjects: 67
Study 35361560 — intervention group
Group type: COMPARATOR
Intervention: Control (ad libitum energy intake)
Number of subjects: 67
Study 35361560 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting
Number of subjects: 67
Study 32784845 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrying police equipment (≈3.5 kg)
Number of subjects: 275
Study 35793700 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐Screening protocol
Number of subjects: 302295
Study 35793700 — intervention group
Group type: COMPARATOR
Intervention: LBC‐Screening protocol
Number of subjects: 302295
Study 34223671 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF) as the prevailing rhythm
Number of subjects: 150
Study 34223671 — intervention group
Group type: COMPARATOR
Intervention: Sinus rhythm
Number of subjects: 150
Study 32659313 — intervention group
Group type: EXPERIMENTAL
Intervention: DBV712 250 μg (epicutaneous immunotherapy)
Number of subjects: 141
Study 34428630 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling for Alcohol Problems (CAP) & enhanced usual care (EUC)
Number of subjects: 512
Study 34428630 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) only
Number of subjects: 512
Study 34604692 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofortified pearl millet
Number of subjects: 11
Study 34604692 — intervention group
Group type: COMPARATOR
Intervention: Sweet potato or sweet potato + pulse
Number of subjects: 11
Study 34604692 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple crop combinations of biofortified crops
Number of subjects: 11
Study 35817694 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative cholangiography (IOC)
Number of subjects: 122
Study 35817694 — intervention group
Group type: COMPARATOR
Intervention: Magnetic resonance cholangiopancreatography (MRCP)
Number of subjects: 122
Study 33373017 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery access
Number of subjects: 80
Study 33373017 — intervention group
Group type: COMPARATOR
Intervention: Femoral artery access
Number of subjects: 80
Study 34264001 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sacropexy (LS)
Number of subjects: 220
Study 34264001 — intervention group
Group type: COMPARATOR
Intervention: Transvaginal mesh (TVM)
Number of subjects: 220
Study 32275028 — intervention group
Group type: EXPERIMENTAL
Intervention: GA with HTE (HTE group)
Number of subjects: 80
Study 32275028 — intervention group
Group type: COMPARATOR
Intervention: GA alone (GA group)
Number of subjects: 80
Study 35810043 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.7 mm variable‐angle locking lateral calcaneal plate (Group 1)
Number of subjects: 18
Study 35810043 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.7 mm variable‐angle locking anterolateral calcaneal plate with one 4.5 mm and one 6.5 mm cannulated screws (Group 2)
Number of subjects: 18
Study 35810043 — intervention group
Group type: EXPERIMENTAL
Intervention: Interlocking calcaneal nail with 3.5 mm screws and three separate 4.0 mm cannulated screws (Group 3)
Number of subjects: 18
Study 32666858 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 327
Study 32666858 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 327
Study 34511585 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar-type hybrid assistive limb (HAL) during sit-to-stand exercise
Number of subjects: 28
Study 34511585 — intervention group
Group type: COMPARATOR
Intervention: Non-HAL during sit-to-stand exercise
Number of subjects: 28
Study 34511585 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HAL and non-HAL groups during sit-to-stand exercise
Number of subjects: 28
Study 34569552 — intervention group
Group type: EXPERIMENTAL
Intervention: Counter-irrigation technique (Group A)
Number of subjects: 48
Study 34569552 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (Group B)
Number of subjects: 48
Study 34454995 — intervention group
Group type: EXPERIMENTAL
Intervention: SIRT+sorafenib
Number of subjects: 282
Study 34454995 — intervention group
Group type: COMPARATOR
Intervention: sorafenib alone
Number of subjects: 282
Study 33119142 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Patient Profile‐Prostate (P3P)
Number of subjects: 295
Study 33119142 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 295
Study 32573058 — intervention group
Group type: EXPERIMENTAL
Intervention: EBNA1+ NPC cells
Number of subjects: 0
Study 616873944 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy with stent retrievers
Number of subjects: 0
Study 616873944 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow-diverting stents
Number of subjects: 0
Study 616873944 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting with embolic protection and plaque imaging
Number of subjects: 0
Study 616873944 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical management with interventional therapy
Number of subjects: 0
Study 616873944 — intervention group
Group type: COMPARATOR
Intervention: Medical management alone
Number of subjects: 0
Study 35256247 — intervention group
Group type: EXPERIMENTAL
Intervention: Damask rose aromatherapy
Number of subjects: 80
Study 35256247 — intervention group
Group type: COMPARATOR
Intervention: Placebo (paraffin oil)
Number of subjects: 80
Study 34694643 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendoscopic peritendon shaving
Number of subjects: 23
Study 34694643 — intervention group
Group type: COMPARATOR
Intervention: Placebo tendoscopic treatment
Number of subjects: 23
Study 32844909 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation physiotherapy applied three times a day starting gait training on the first day
Number of subjects: 48
Study 32844909 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy applied once a day starting gait training on the second or third day
Number of subjects: 48
Study 34555263 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy with conservation of one or both adnexa
Number of subjects: 202506
Study 34555263 — intervention group
Group type: COMPARATOR
Intervention: Intact uterus
Number of subjects: 202506
Study 34555263 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 202506
Study 35596020 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailouts plus telephone support
Number of subjects: 497
Study 35596020 — intervention group
Group type: COMPARATOR
Intervention: Mailouts alone
Number of subjects: 497
Study 33220329 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g MCT/day
Number of subjects: 30
Study 33220329 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 g MCT/day
Number of subjects: 30
Study 33220329 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 g MCT/day)
Number of subjects: 30
Study 33220329 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT (12 g and 18 g)
Number of subjects: 30
Study 32002593 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg adrenaline via intraosseous route
Number of subjects: 7317
Study 32002593 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg adrenaline via intravenous route
Number of subjects: 7317
Study 32002593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7317
Study 34462921 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent feeding
Number of subjects: 0
Study 34462921 — intervention group
Group type: COMPARATOR
Intervention: Continuous feeding
Number of subjects: 0
Study 34489390 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-field IMRT with chemotherapy
Number of subjects: 34
Study 34489390 — intervention group
Group type: COMPARATOR
Intervention: Pelvic-field IMRT with chemotherapy
Number of subjects: 34
Study 36171582 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 200 mg daily, vitamin C 2 g every 6 hours, thiamine 200 mg every 12 hours
Number of subjects: 408
Study 36171582 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 408
Study 36171582 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone, vitamin C, thiamine
Number of subjects: 408
Study 36171582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 408
Study 34539786 — intervention group
Group type: EXPERIMENTAL
Intervention: CM‐LOC attachment
Number of subjects: 80
Study 34539786 — intervention group
Group type: COMPARATOR
Intervention: Ball attachment
Number of subjects: 80
Study 33185364 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 0.1 mg
Number of subjects: 320
Study 33185364 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 0.2 mg
Number of subjects: 320
Study 33185364 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous semaglutide 0.4 mg
Number of subjects: 320
Study 33185364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study 32444056 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine solution (DS)
Number of subjects: 70
Study 32444056 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine-containing glycyrrhiza glabra (DSG)
Number of subjects: 70
Study 36089706 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic approach of tunica vaginalis
Number of subjects: 80
Study 36089706 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgery
Number of subjects: 80
Study 32515694 — intervention group
Group type: EXPERIMENTAL
Intervention: PIV ≤ 7 mL (25th percentile)
Number of subjects: 315
Study 32515694 — intervention group
Group type: EXPERIMENTAL
Intervention: PIV ≥ 72 mL (75th percentile)
Number of subjects: 315
Study 32515694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment factors for small-PIV/mRS ≥ 3
Number of subjects: 315
Study 32515694 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment factors for small-PIV/mRS ≥ 3
Number of subjects: 315
Study 32515694 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors for large-PIV/mRS ≤ 2
Number of subjects: 315
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV
Number of subjects: 931
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: hMPV
Number of subjects: 931
Study 35882541 — intervention group
Group type: EXPERIMENTAL
Intervention: hRV/EV
Number of subjects: 931
Study 32795561 — intervention group
Group type: EXPERIMENTAL
Intervention: Liuzijue Qigong combined with conventional rehabilitation training
Number of subjects: 60
Study 32795561 — intervention group
Group type: COMPARATOR
Intervention: Conventional respiratory training combined with conventional rehabilitation training
Number of subjects: 60
Study 32859308 — intervention group
Group type: EXPERIMENTAL
Intervention: 2019 ESPEN guidelines
Number of subjects: 152
Study 32859308 — intervention group
Group type: COMPARATOR
Intervention: 2016 ASPEN guidelines
Number of subjects: 152
Study 32859308 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition (ESPEN)
Number of subjects: 152
Study 32859308 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition (ASPEN)
Number of subjects: 152
Study 32859308 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (ESPEN)
Number of subjects: 152
Study 32859308 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition (ASPEN)
Number of subjects: 152
Study 35778995 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) using ropivacaine, epinephrine, ketorolac, and normal saline solution.
Number of subjects: 74
Study 35778995 — intervention group
Group type: COMPARATOR
Intervention: Interscalene block using liposomal bupivacaine.
Number of subjects: 74
Study 35778995 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 74
Study 35778995 — intervention group
Group type: COMPARATOR
Intervention: Interscalene block
Number of subjects: 74
Study 33944875 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose csDMARDs (n=80)
Number of subjects: 160
Study 33944875 — intervention group
Group type: COMPARATOR
Intervention: Stable-dose csDMARDs (n=80)
Number of subjects: 160